Targeting tachykinin receptors in neuroblastoma

Neuroblastoma is the most common extracranial tumor in children. Despite aggressive multimodal treatment, high-risk neuroblastoma remains a clinical challenge with survival rates below 50%. Adding targeted drugs to first-line therapy regimens is a promising approach to improve survival in these pati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Henssen, Anton G., Odersky, Andrea, Szymansky, Annabell, Seiler, Marleen, Althoff, Kristina, Beckers, Anneleen, Speleman, Frank, Schäfers, Simon, De Preter, Katleen, Astrahanseff, Kathy, Struck, Joachim, Schramm, Alexander, Eggert, Angelika, Bergmann, Andreas, Schulte, Johannes H.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352132/
https://ncbi.nlm.nih.gov/pubmed/27888795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13440
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares